Published: 01-08-2016
Review
The Association between ANXA11 Gene Polymorphisms and Sarcoidosis: a Meta-Analysis and systematic review
Abstract 103 | PDF Downloads 96Page 102-111
An epidemiological perspective of the pathology and etiology of sarcoidosis
Abstract 115 | PDF Downloads 145Page 112-116
Original Articles: Clinical Research
High-resolution CT predictors of hypersensitivity pneumonitis
Abstract 149 | PDF Downloads 174Page 117-123
Fatigue and health-related quality of life in patients with pulmonary sarcoidosis treated by oral Corticosteroids
Abstract 193 | PDF Downloads 226Page 124-129
Fatigue in sarcoidosis and idiopathic pulmonary fibrosis: differences in character and severity between diseases
Abstract 136 | PDF Downloads 202Page 130-138
Serum fibroblastic growth factor 23 in acute Sarcoidosis and normal kidney function
Abstract 127 | PDF Downloads 96Page 139-142
Platelet aggregability in patients with interstitial pneumonias
Abstract 109 | PDF Downloads 98Page 143-150
Evaluation of Tpeak-Tend interval and Tpeak-end/QT ratio in patients with Sarcoidosis
Abstract 187 | PDF Downloads 147Page 151-156
Exercise related ventilation dynamics and clinical correlates in patients with fibrotic idiopathic interstitial pneumonias
Abstract 126 | PDF Downloads 109Page 157-165
Case Reports
Polishing surgical metal pieces, granulomatosis and mineralogical analysis
Abstract 179 | PDF Downloads 86Page 166-170
Pulmonary metastases from low grade sarcoma in a patient with pulmonary sarcoidosis. Sarcoidosis or sarcoid-like reaction?
Abstract 97 | PDF Downloads 127Page 171-174
Cardiac sarcoidosis – silent destroyer.
Abstract 92 | PDF Downloads 98Page 175-177
Sarcoidosis during etanercept treatment for rheumatoid arthritis in women with a history of bilateral oophorectomy
Abstract 126 | PDF Downloads 85Page 178-181
Extensive pulmonary sarcoid reaction in a patient with BMPR-2 associated idiopathic pulmonary arterial hypertension
Abstract 166 | PDF Downloads 76Page 182-185
Successful management of acute respiratory failure in an Idiopathic Pulmonary Fibrosis patient using an extracorporeal carbon dioxide removal system
Abstract 131 | PDF Downloads 182Page 186-190
Letter to Editor
Repositioning ‘old’ drugs to treat rare diseases: arguing from the mechanism of action
Abstract 189 | PDF Downloads 92Page 191-194